Applied Statistics

Biology: Genentech

Total Score People Score Events Score
33 26 25
Date Event Presentation Speakers
April 2, 2016 Modern Phenotypic Drug Discovery: Defining the Path Forward Why Revisit PDD? John Moffat
Keynote Address John Moffat
Panel 2: Identification of Molecular Targets and Biological "Mechanisms of Action": How Much is Enough? John Moffat
Target/MOA Identification/Deconvolution John Moffat
January 24, 2016 10th PMWC 2016 Personalized Medicine World Conference TRACK 2 | Disease Heterogeneity and Drug Response in Rheumatoid Arthritis MICHAEL TOWNSEND
March 2, 2014 Alzheimer’s Disease – From Fundamental Insights to Light at the End of the Translational Tunnel (Q8) Phenotypic and Genotypic Complexity of AD and PD (Joint) Registered attendees can view abstracts starting on 02/02/2014 Ryan J. Watts
February 10, 2014 Predictive Preclinical Models in Oncology Modeling Efficacy and Resistance of Hedgehog Pathway Inhibitors in Cancer Frederic J. de Sauvage
February 2, 2014 Developmental Pathways and Cancer: Wnt, Notch and Hedgehog (J7) Stem Cells, Development and Cancer (Joint) Registered attendees can view abstracts starting on 01/02/2014 Frederic J. de Sauvage
Targeting Cancer Stem Cells: Trials and Translation Registered attendees can view abstracts starting on 01/02/2014 Vishva M. Dixit
Targeting Developmental Pathways: Clinical Experience Frederic J. de Sauvage
New Regulatory Pathways in Cancer Registered attendees can view abstracts starting on 01/02/2014 Vishva Dixit
Emerging Cancer Drug Targets in Development Pathways Registered attendees can view abstracts starting on 01/02/2014 Weilan Ye
January 17, 2014 (J3) Keystone Symposia: Emerging Cytokine Networks Targeting Immune Modulators in Autoimmunity and Cancer (Joint) Registered attendees can view abstracts starting on 12/17/2013 Ira Mellman
May 31, 2013 ASCO Annual Meeting 2013 The Many Faces of Hepatocellular Carcinoma: From Biology to Treatment Robert Kelley
April 6, 2013 AACR Annual Meetings Expanding the Druggable Genome Chairperson: Stephen W. Fesik, Vanderbilt University School of Medicine, Nashville, TN Domagoj Vucic
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Peter K Jackson
March 3, 2013 Understanding Dendritic Cell Biology to Advance Disease Therapies (C2) Harnessing DC Biology to Advance Disease Therapies Ira Mellman
Translating DC Biology into Medicine Ira Mellman
February 10, 2013 7thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE: An Intensive Course on Translating Research into Drugs Antibodies and Immunotherapy for Neurodegeneration Ryan J. Watts
February 3, 2013 Neurogenesis (J7) Neurobiology of Disease Ryan J. Watts, Marc Tessier Lavigne
January 31, 2013 11th Cytokines and Inflammation Ubiquitination Regulates TNF Family Signaling Domagoj Vucic
February 13, 2011 Inositide Signaling in Pharmacology and Disease (X1) PI 3-Kinases (X2) | Clinical Development Strategies of PI3K/mTOR Inhibitors Mika Derynck
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Dendritic Cells (J7) | MHC Class II Pathways Ira Mellman
May 19, 2010 Towards Personalized Cancer Medicine Role of the Microenvironment in VEGF-Independent Angiogenesis Napoleone Ferrara
November 10, 2009 Immunomodulating Therapies and Progressive Multifocal Leukoencephalopathy (PML) Session IV: PML Association With Tysabri, Raptiva and Rituxan Theraputics David Yocum
August 5, 2009 New Frontiers in Cancer Drug Development Cancer Stem Cells Chia Portera
Targeting the Hedgehog Pathway in Cancer Treatment Chia Portera
Bevacizumab in Patients with Previously Treated Glioblastoma Asha Das
June 9, 2009 RNAi for Target Identification and Validation Unlocking the Genome with Pooled shRNA Screens David P. Davis
January 26, 2009 7th Annual Partnering with Central Labs B1 : How to Reduce the Burden on Smaller Sponsor Clinical Team-The Cross Functional Approach Rhonda Benotti
Track A : Best Practices for Collecting and Integrating Data in International Clinical Trials Elena Gogoleva
December 7, 2008 Antibody Engineering Highly Functional Minimalist Antibodies Sachdev Sidhu
July 19, 2008 22nd Annual Symposium of The Protein Society Concurrent Afternoon Symposia 9: New Methods for Engineering Recognition Sachdev Sidhu
May 30, 2008 ASCO Annual'08 Meeting professional development-- Contract Negotiations for Your First Job in Industry, Private Practice, or Academia Sean P. Bohen
February 10, 2008 GRC - Plasminogen Activation & Extracellular Proteolysis The transmembrane serine protease hepsin activates pro-hepatocyte growth factor (HGF) and pro-urokinase plasminogen activator (uPA) and promotes tumor progression Daniel Kirchhofer
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 7: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part II) (09:00-12:00) Mark S. Dennis
Session 7: Tumor Targeting with an AB.Fab (09:00-09:20) Mark S. Dennis
June 16, 2007 Biology and Chemistry of Vision A Core Complex of BBS Proteins Cooperates with the Maxence V Nachury
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.